ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Human Adipose Tissue Derived Mesenchymal Stem Cells Aggravate Chronic Cyclosporin Nephrotoxicity by the Induction of Oxidative Stress

B. Chung, S. Lim, K. Doh, S. Piao, S. Heo, C. Yang

Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea

Meeting: 2013 American Transplant Congress

Abstract number: C1211

Cyclosporine (CsA) induced nephrotoxicity is an important complications to limit the long term allograft outcome in kidney transplantation. The aim of this study was to investigate whether the immune modulating and tissue repairing effect of human-adipose tissue derived mesenchymal stem cells (hATMSCs) could protect against chronic cyclosporin (CsA)-induced renal injury in an experimental model. CsA (7.5 mg/kg) and hATMSCs (3 * 106/5 mL) were administered alone and together to Sprague Dawley rats for 4 weeks. The effect of hATMSCs on CsA-induced renal injury was evaluated by assessing renal function, interstitial fibrosis, infiltration of inflammatory cells, and apoptotic cell death. Four weeks of CsA treatment produced typical chronic CsA nephropathy. Combined treatment with CsA and hATMSCs did not prevent these effects and showed a trend toward further renal deterioration. To evaluate why hATMSCs aggravated CsA-induced renal injury, we measured oxidative stress, a major mechanism of CsA-induced renal injury. Both urine and serum 8-hydroxydeoxyguanosine (8-OHdG) levels were higher in the CsA + hATMSC group than in the CsA group (P < 0.05). An in vitro study showed similar results. Although the rate of apoptosis did not differ significantly between HK-2 cells cultured in hATMSCs conditioned medium and those cultured in DMEM, addition of CsA resulted in greater apoptosis in HK-2 cells cultured in hATMSCs conditioned medium. Addition of CsA increased the levels of nitric oxide and 8-OHdG in the hATMSCs-conditioned culture medium. The results of our in vivo and in vitro study suggest that treatment with hATMSCs may provide an oxidative stress-associated harmful effect on CsA-induced renal injury.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Chung B, Lim S, Doh K, Piao S, Heo S, Yang C. Human Adipose Tissue Derived Mesenchymal Stem Cells Aggravate Chronic Cyclosporin Nephrotoxicity by the Induction of Oxidative Stress [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/human-adipose-tissue-derived-mesenchymal-stem-cells-aggravate-chronic-cyclosporin-nephrotoxicity-by-the-induction-of-oxidative-stress/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences